Nanoneedle breakthrough gives hope for cheaper cancer treatment [24-08-2023]
A multidisciplinary team led by ARC Future Fellow Dr. Roey Elnathan, from Deakin University´s School of Medicine, and ARC Laureate Professor Nicolas Voelcker, from Monash University´s Institute of Pharmaceutical Sciences (MIPS), has harnessed the power of nano-injection technology to improve outcomes in one of the world´s newest forms of cancer immunotherapies, CAR-T cell therapy.
Related News
Nanobots Therapeutics successfully closes a Pre-Seed funding round of €478,000 [22-09-2023]
Nanobiotechnology, Nanomedicine
Postdoctoral fellowship for Women in Science [21-09-2023]
Nanobiotechnology, Nanotechnologies
NBRAIN Neuroelectronics Announces FDA Breakthrough Device Designation for Its Graphene-Based Intelligent Network Modulation Platform [19-09-2023]
Nanomedicine, Graphene
Precisely arranging nanoparticles [19-09-2023]
Plasmonics, Nanotechnologies
Observing nanoparticles with unprecedented precision [15-09-2023]

© Phantoms Foundation 2023